RE-PB HYOS ELIXIR (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the RE-PB HYOS ELIXIR drug offered from KAISER FOUNDATION HOSPITALS. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
NON-PROPRIETARY NAME: | BELLADONNA ALKALOIDS W/ PHENOBARBITAL |
SUBSTANCE NAME: | PHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | ELIXIR |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2009-10-20 |
END MARKETING DATE: | 0000-00-00 |
RE-PB HYOS ELIXIR HUMAN PRESCRIPTION DRUG Details:
Item Description | RE-PB HYOS ELIXIR from KAISER FOUNDATION HOSPITALS |
LABELER NAME: | KAISER FOUNDATION HOSPITALS |
DEA SCHEDULE: | CIV
|
ACTIVE STRENGTH: | 16.2; .1037; .0194; .0065(mg/5mL; mg/5mL; mg/5mL; mg/5mL) |
START MARKETING DATE: | 2009-10-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0179-0036_46046ad1-f5b9-4f0a-9e77-a0f466b079f4 |
PRODUCT NDC: | 0179-0036 |
APPLICATION NUMBER: | |
Other PHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: